Edition:
India

Hisamitsu Pharmaceutical Signs Agreement With Kyowa Hakko Kirin For Parkinson's Disease Treatment Hisamitsu Is Developing


Tuesday, 5 Feb 2019 

Feb 5 (Reuters) - Hisamitsu Pharmaceutical Co Inc <4530.T>::SIGNED SALES AGREEMENT WITH KYOWA HAKKO KIRIN FOR PARKINSON'S DISEASE TREATMENT HISAMITSU IS DEVELOPING.KYOWA HAKKO KIRIN WILL SELL ITS PARKINSON'S DISEASE TREATMENT IN JAPAN ONCE ITS APPLICATION IS APPROVED.EXPECTS ITS APPLICATION FOR MANUFACTURE AND SALES WILL BE APPROVED BY FEB 2020. 

Company Quote

2113.0
33.0 +1.59%
19 Sep 2019